Special Issue "Recent Trends in Drug Screening, Development and Delivery"

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".

Deadline for manuscript submissions: 31 March 2024 | Viewed by 386

Special Issue Editors

Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan
Interests: gut microbiota; antimicrobial resistance; One Health; environmental microbiology; antimicrobial resistance genes
Special Issues, Collections and Topics in MDPI journals
Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
Interests: drug delivery; lipid based formulations; vesicles formulations; solubility enhancement
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The screening and development of drugs are the principal steps to commercialize advanced pharmaceutical and biotechnology products to fulfill the need of clinical settings. The continued developments in the field of “drug discovery” provide an endless source of candidate drugs that could be approved for clinical use after preclinical and clinical trials. The novel approaches being used for drug discovery and development are of paramount interest to all the stakeholders of the healthcare industry including patients, clinicians, and pharmaceutical and biotechnology companies. The development of new tools and the improvements of existing tools are helping chemists in the drug discovery process extending from the candidate molecules to clinically useful drugs. Such innovations encompass improved drug screening protocols, in silico approaches, computational tools for toxicity analysis, advances in molecular biology and combinatorial chemistry that have simplified the screening and identification of numerous molecular targets simultaneously, and the development of novel screening methods. These new approaches are expected to increase the probability of success for any particular drug candidate, decrease the time and cost of development of drugs from a concept to market that will facilitate human efforts towards the development of cost-effective, clinically efficient, and safer pharmaceutical and biotechnology products offering enhanced clinical outcomes. The drug delivery process uses various formulation development approaches to make consuming drugs easier, less frequent and more effective for patients. 

This Special Issue, “Recent Trends in Drug Screening, Development and Delivery”, is focused on but not limited to newer approaches in the form of original research articles and reviews related to the various aspects of methodologies for the discovery of various agents and will present the recent trends in research related to the discovery, development, and all delivery aspects of drugs, pharmaceuticals and biotechnology products. 

Dr. Mohsin Khurshid
Dr. Abdul Ahad
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • drug development
  • drug delivery
  • computational methods
  • target binding
  • structural data
  • natural products
  • toxicology
  • toxicity prediction
  • formulation development

Published Papers

This special issue is now open for submission.
Back to TopTop